NaviFUS Corp. (TPEX:6872)

Market Cap	1.44B
Revenue	n/a
Net Income	n/a
Shares Out	70.74M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	55,263
Average Volume	54,897
Open	20.30
Previous Close	20.15
Day's Range	20.00 - 20.60
52-Week Range	20.00 - 41.00
Beta	0.19
RSI	32.38
Earnings Date	May 13, 2025

About NaviFUS

NaviFUS Corp., a medical device company, develops and sells focused ultrasound (FUS) solutions for the unmet needs in neuromedicine in Taiwan. The company develops NaviFUS, a neuronavigator-guided transcranial FUS system that delivers focal energy into deep tissues in the brain, as well as is used in various clinical applications, such as drug delivery, neuromodulation, immuno-stimulation, and others. It also develops NAVIRFA, a navigation system that uses optical 3D surgical tracking technology to monitor the 3D position of the needle tip duri...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2015
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6872